Pacira Pharmaceuticals Announces Proposed Offering of $100 Million of Convertible Senior Notes

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX ) (the “Company”) today announced that it proposes to offer $100 million of aggregate principal amount of its convertible senior notes due 2019, subject to market conditions and other factors. The notes are to be offered and sold only to qualified institutional buyers pursuant